Xtx Markets »

Oncternal Therapeutics shares owned by Xtx Markets

Quarter-by-quarter ownership of Oncternal Therapeutics shares owned by Xtx Markets from 13F filings

Historical chart of Xtx Markets investment in Oncternal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oncternal Therapeutics held by Xtx Markets consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncternal Therapeutics by Xtx Markets

Quarter filed Position value Share count Share price at filing
2020-12-31 $53k 11k 4.93

More positions owned by Xtx Markets

Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
stock
Lockheed Martin Corporation (LMT)
Palo Alto Networks (PANW)
Mastercard Incorporated Cl A (MA)
Okta Cl A (OKTA)
Burlington Stores (BURL)
Uber Technologies (UBER)
Twilio Cl A (TWLO)
Ansys (ANSS)
John Bean Technologies Corporation (JBT)
Seattle Genetics
Thermo Fisher Scientific (TMO)
Mettler-Toledo International (MTD)

View all positions for Xtx Markets

Top funds holding Oncternal Therapeutics

Vanguard Group
Millennium Management
Richmond Brothers
Ieq Capital
Two Sigma Advisers
Two Sigma Investments
Axxcess Wealth Management
Two Sigma Securities
Citadel Advisors
Regents of the University of California
Balboa Wealth Partners
Creative Planning
Charles Schwab Investment Management
Beta Wealth
IPG Investment Advisors

View all funds holding Oncternal Therapeutics